Fundraising FoxStemInov
2 known investors
Find your way into StemInov
Sign up to see every warm intro you have to StemInov
- Paths you didn't know you had: your email and LinkedIn already hold routes to the StemInov team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
StemInov is a biotech developing WhartSep, an off-the-shelf stem cell therapy derived from umbilical cord (Wharton's jelly) cells with three complementary actions to treat severe pneumonia and sepsis. The company targets immune disorders and tissue repair as unmet medical needs.
Founders & leadership
JH
Julie HutinCEO & Co-founder
DB
Danièle BensoussanCSO & Co-founder
PC
PE CharlesClinical Strategy
CD
Claude DedryCMC
Investors · 2
Frequently asked questions
- What does StemInov do?
- StemInov is a biotech developing WhartSep, an off-the-shelf stem cell therapy derived from umbilical cord (Wharton's jelly) cells with three complementary actions to treat severe pneumonia and sepsis. The company targets immune disorders and tissue repair as unmet medical needs.
- Who founded StemInov?
- StemInov was founded by Julie Hutin, Danièle Bensoussan.
- Who are StemInov's investors?
- StemInov's investors include Angels Santé, Business Angels des Grandes Ecoles.